Faculty profile

Avram Denburg

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Avram Denburg

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
42 publications in the last five years, latest in 2026.
Senior (last) author on 15 recent papers, a sign of leading a research group.
Principal investigator on 7 research grants (7 CIHR), most recently in 2024.
Supervisor on 4 trainee awards (4 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

470

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Pediatric Cancer Implementation Research Next-Generation Sequencing Patient-Reported Outcomes Precision Oncology Psychosocial Impacts Children And Youth Health Systems

Latest papers

Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers
Frontiers in Pediatrics · 2026
The Patient-reported Genetic testing Utility InDEx: A novel measure of personal utility.
Genetics in medicine : official journal of the American College of Medical Genetics · 2026
Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.
NPJ genomic medicine · 2026

All 56 publications

Latest funding

The sustainability of evidence-based innovations in public health and health care settings in low- and middle-income countries: An evaluation of early detection program in Cameroon
CIHR · 2025 · Supervisor
$6,000
An Implementation Evaluation of the Look Again Campaign: A Childhood Cancer Early Detection and Referral Intervention in a Low-and Middle-Income Country Health System, in Lagos, Oyo and Ogun States of Southwest Nigeria
CIHR · 2025 · Supervisor
$120,000
Towards patient-centred precision oncology care for children and youth: Understanding psychosocial impacts and experiences through patient and professional perspectives
CIHR · 2024 · Nominated PI
$1,013,626

All 13 grants and awards

56 publications.

Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers

Kumar K, Denburg A, Cressman C, Tsang DS, Romanick M, Rodrigues M, Gibson PJ

Frontiers in Pediatrics2026

DOI: 10.3389/fped.2026.1793250

The Patient-reported Genetic testing Utility InDEx: A novel measure of personal utility.

Poole E, Xiao B, Luca S, Assamad D, Abbott LS, Armstrong L, Boycott KM, Carroll JC, Chad L, De Bie I, Denburg A, Deyell RJ, Elliott AM, Goudie C, Laberge AM, Mucha BE, Peltekova IT, Quinlan B, Sawyer SL, Smith M, Villani A, Ungar WJ, Hayeems RZ, P-GUIDE Study Team

Genetics in medicine : official journal of the American College of Medical Genetics2026

DOI: 10.1016/j.gim.2026.102670 PMID: 42554147

Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.

Raiti L, Yuki KE, Cinq-Mars L, Higginbotham EJ, Navickiene V, Li Y, Wang Z, Thiruv B, Charlinski T, Gallinger B, Venier RE, Huang A, Denburg A, Chun K, Villani A

NPJ genomic medicine2026

DOI: 10.1038/s41525-026-00584-x PMID: 42248890

Cost-Effectiveness of Dabrafenib Plus Trametinib Versus Standard Chemotherapy in BRAFV600E-Mutant Pediatric Low-Grade Glioma.

Gascon B, Gauvreau C, Yang A, Bennett J, Nobre L, Tabori U, Hawkins C, Tsang D, Pechlivanoglou P, Denburg A

JCO oncology practice2026Senior author

DOI: 10.1200/op-25-01263 PMID: 41740060

Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review.

Lau E, Koo A, Kang HB, Ames M, Matinnia C, Denburg A

Pharmaceutical medicine2026Senior author

DOI: 10.1007/s40290-025-00593-8 PMID: 41324794

Pediatric Oncology Progress and Challenges in Southeast Asia: Strengthening Cancer Care Systems.

Tang A, Treechairusame T, Saguil E, Go AE, Ting FIL, Knopf K, Denburg A, Gunasekera S, Bhoo-Pathy N, Dee EC, Columbres RC

Pediatrics2026

DOI: 10.1542/peds.2025-075007 PMID: 42448335

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Chan KK-W, Takhar P, Evans WK, Mercer RE, Denburg A, Beca J, Muñoz C, Gavura S, Cheung WY, Hoch J

BMJ Open20254 citations

DOI: 10.1136/bmjopen-2024-096286

Listening to the lost voices: a qualitative study reflecting on medical assistance in dying for mature minors in Ontario

Campbell S, Moola F, Denburg A, Gibson J, Petch J

Paediatrics and Child Health20251 citations

DOI: 10.1093/pch/pxaf025

Feasibility and clinical and implementation effectiveness of an adapted early warning signs and symptoms intervention for the early detection of childhood cancer in Cameroon and Kenya: protocol for a quasi-experimental, hybrid type 2 implementation effectiveness study.

Noh H, Chelva MP, Mbah Afungchwi G, Pondy A, Githanga J, Landis F, King'e M, Martiniuk AL, Ward N, Barwick M, Gupta S, Denburg A

BMJ open2025Senior author

DOI: 10.1136/bmjopen-2024-094502 PMID: 40897493

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Muñoz CE, Dai WF, Cheung WY, de Oliveira C, Pataky RE, Ding PQ, Tran DA, Aurangzeb Z, Nagamuthu C, Liu N, Lethbridge L, McClure C, Vriends K, Xiong H, Folkins C, Somayaji C, Peacock S, Alvi R, Turner D, O'Conaill C, McDonald T, Urquhart R, Kendell C, Dowden J, Strumpf E, Denburg A, Beca JM, Mercer RE, Tadrous M, Takhar P, Chan KKW, CanREValue Collaboration

International journal of cancer2025

DOI: 10.1002/ijc.35448 PMID: 40268528

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Pediatric Cancer Dear Professor Denburg, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Towards patient-centred precision oncology care for children and youth: Understanding psychosocial impacts and experiences through patient and professional perspectives" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Avram Denburg

Research

Latest papers

Latest funding

Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers

The Patient-reported Genetic testing Utility InDEx: A novel measure of personal utility.

Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.

Cost-Effectiveness of Dabrafenib Plus Trametinib Versus Standard Chemotherapy in BRAFV600E-Mutant Pediatric Low-Grade Glioma.

Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review.

Pediatric Oncology Progress and Challenges in Southeast Asia: Strengthening Cancer Care Systems.

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Listening to the lost voices: a qualitative study reflecting on medical assistance in dying for mature minors in Ontario

Feasibility and clinical and implementation effectiveness of an adapted early warning signs and symptoms intervention for the early detection of childhood cancer in Cameroon and Kenya: protocol for a quasi-experimental, hybrid type 2 implementation effectiveness study.

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Frequent collaborators

Sumit Gupta

Mina Tadrous

Petros Pechlivanoglou

Jeremy Petch

Maureen Trudeau

Jeremy Petch

Stuart Peacock

Fiona Moola

Claire de Oliveira

Catherine Goudie

Yvonne Bombard

Stuart Peacock

Fiona Moola

Cynthia Kendell

Lauren Chad

Melanie Barwick

Eric Bouffet

Ronald Duncan Barr

William Evans

Uri Tabori

Erin Strumpf

Cynthia Hawkins

Jennifer Gibson

Anne-Marie Laberge

Cindy Gauvreau

Alexandra Martiniuk

Ning Liu

Derek Tsang

Winson Cheung

Maureen Smith

Upton Allen

Lesa Dawson